Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Zbigniew K . Wszolek, M.D.

Back to Research Profile

  1. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009 Dec; 8(12):1150-7.
    View PubMed
  2. Wider C, Vilarino-Guell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Association of the MAPT locus with Parkinson's disease. Eur J Neurol 2009 Nov 12. [Epub ahead of print]
    View PubMed
  3. Puschmann A, Ross OA, Vilarino-Guell C, Lincoln SJ, Kachergus JM, Cobb SA, Lindquist SG, Nielsen JE, Wszolek ZK, Farrer M, Widner H, van Westen D, Hagerstrom D, Markopoulou K, Chase BA, Nilsson K, Reimer J, Nilsson C. A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat Disord 2009 Nov; 15(9):627-32. Epub 2009 Jul 25.
    View PubMed
  4. Cobb SA, Wider C, Ross OA, Mata IF, Adler CH, Rajput A, Rajput AH, Wu RM, Hauser R, Josephs KA, Carr J, Gwinn K, Heckman MG, Aasly JO, Lynch T, Uitti RJ, Wszolek ZK, Kapatos G, Farrer MJ. GCH1 in early-onset Parkinson's disease. Mov Disord 2009 Oct 30; 24(14):2070-5.
    View PubMed
  5. Wider C, Lincoln S, Dachsel JC, Kapatos G, Heckman MG, Diehl NN, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Dickson DW, Wszolek ZK, Farrer MJ. GCH1 expression in human cerebellum from healthy individuals is not gender dependent. Neurosci Lett 2009 Oct 2; 462(1):73-5. Epub 2009 Jun 30.
    View PubMed
  6. Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Josephs KA. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology 2009 Sep 29; 73(13):1058-65.
    View PubMed
  7. Keeling BH, Vilarino-Guell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, Wszolek ZK, Farrer MJ. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor. Parkinsonism Relat Disord 2009 Sep 19. [Epub ahead of print]
    View PubMed
  8. Keeling BH, Vilarino-Guell C, Ross OA, Wszolek ZK, Uitti RJ, Farrer MJ. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci Lett 2009 Sep 18; 461(2):74-5. Epub 2009 Jun 12.
    View PubMed
  9. Wider C, Dachsel JC, Farrer MJ, Dickson DW, Tsuboi Y, Wszolek ZK. Elucidating the genetics and pathology of Perry syndrome. J Neurol Sci 2009 Sep 02. [Epub ahead of print]
    View PubMed
  10. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2009 Aug 31. [Epub ahead of print]
    View PubMed
  11. Soto-Ortolaza AI, Behrouz B, Wider C, Vilarino-Guell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Calbindin-1 association and Parkinson's disease. Eur J Neurol 2009 Aug 05. [Epub ahead of print]
    View PubMed
  12. Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J. Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat Disord 2009 Aug; 15(7):539-41. Epub 2008 Nov 28.
    View PubMed
  13. Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease. Eur J Neurol 2009 Aug; 16(8):909-11. Epub 2009 Mar 31.
    View PubMed
  14. Sitek EJ, Narozanska E, Slawek J, Wieczorek D, Brockhuis B, Lass P, Dubaniewicz M, Jasinska-Myga B, Baker M, Rademakers R, Wszolek ZK. Unilateral neglect in a patient diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17. Acta Neuropsychiatr 2009 Aug; 21(4):209-10.
    View PubMed
  15. Vilarino-Guell C, Chai H, Keeling BH, Young JE, Rajput A, Lynch T, Aasly JO, Uitti RJ, Wszolek ZK, Farrer MJ, Lin SC. MEIS1 p.R272H in familial restless legs syndrome. Neurology 2009 Jul 21; 73(3):243-5.
    View PubMed
  16. Vilarino-Guell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Destee A, Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 2009 Jun 9; 72(23):2024-8.
    View PubMed
  17. Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology 2009 Jun 2; 72(22):1953-9.
    View PubMed
  18. Puschmann A, Wszolek ZK, Farrer M, Gustafson L, Widner H, Nilsson C. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus? Parkinsonism Relat Disord 2009 Jun; 15(5):390-2. Epub 2008 Sep 27.
    View PubMed
  19. Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 2009 May; 15(4):300-6. Epub 2008 Sep 18.
    View PubMed
  20. Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S. Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 2009 May; 15(4):300-6.
    View PubMed
  21. Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 2009 May; 15(4):281-6. Epub 2008 Aug 23.
    View PubMed
  22. Slowinski JL, Schweitzer KJ, Imamura A, Uitti RJ, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. Brainstem atrophy on routine MR study in pallidopontonigral degeneration. J Neurol 2009 May; 256(5):827-9 Epub 2009 Mar 1.
    View PubMed
  23. Wider C, Dickson DW, Schweitzer KJ, Broderick DF, Wszolek ZK. Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation. J Neurol 2009 May; 256(5):839-42 Epub 2009 Mar 1.
    View PubMed
  24. Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Phactr2 and Parkinson's disease. Neurosci Lett 2009 Mar 27; 453(1):9-11. Epub 2009 Feb 10.
    View PubMed
  25. Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009 Mar 3; 72(9):813-20.
    View PubMed
  26. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Hoglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009 Mar; 16(3):297-309.
    View PubMed
  27. Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Fine-mapping and candidate gene investigation within the PARK10 locus. Eur J Hum Genet 2009 Mar; 17(3):336-43. Epub 2008 Oct 15.
    View PubMed
  28. Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov Disord 2009 Feb 15; 24(3):455-9.
    View PubMed
  29. Young JE, Vilarino-Guell C, Lin SC, Wszolek ZK, Farrer MJ. Clinical and genetic description of a family with a high prevalence of autosomal dominant restless legs syndrome. Mayo Clin Proc 2009 Feb; 84(2):134-8.
    View PubMed
  30. Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilarino-Guell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, DCTN1 mutations in Perry syndrome. Nat Genet 2009 Feb; 41(2):163-5. Epub 2009 Jan 11.
    View PubMed
  31. Vilarino-Guell C, Ross OA, Soto AI, Farrer MJ, Haugarvoll K, Aasly JO, Uitti RJ, Wszolek ZK. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov Disord 2009 Jan 9. [Epub Ahead of print]
    View PubMed
  32. Wider C, Wszolek ZK. Movement disorders: insights into mechanisms and hopes for treatment. Lancet Neurol 2009 Jan; 8(1):8-10.
    View PubMed
  33. Young JE, Vilariño-Güell C, Lin S-C, Wszolek ZK, Farrer MJ. Clinical and genetic description of a family with a high prelalence of autosomal dominant restless legs syndrome. Mayo Clin Proc 2009; 84:134-138.
    View PubMed
  34. Farrer MJ, Hulihan MM, Kachergus JM, Dächsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilariño-Güell C, Ross OA, Brown LA, Castanedes-Casey M, Dick DCTN1 mutations in Perry syndrome. Nature Genetics 2009; 41:163-165.
    View PubMed
  35. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow E-M, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European J Neurol 2009; 16:297-309.
    View PubMed
  36. Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Fine-mapping and candidate gene investigation within the PARK10 locus. European J Hum Genet 2009; 17:336-343.
    View PubMed
  37. Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JO, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. FGF20 and Parkinson’s disease: no evidence of association or pathogenicity via α–synuclein expression. Mov Disord 2009; 24:455-459.
    View PubMed
  38. Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA. Voxel-based morphometry patterns of atrophy in FTLD with mutaions in MAPT or PGRN. Neurology 2009; 72:813-820.
    View PubMed
  39. Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Phactr2 and Parkinson’s disease. Neuroscience Letters 2009; 453:9-11.
    View PubMed
  40. Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, Zhao Y, LeDoux MS. High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genetics 2009; 10:1-10.
    View PubMed
  41. Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 2009; 15:300-306.
    View PubMed
  42. Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disorder 2009; 15:281-286.
    View PubMed
  43. Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J. Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat Disord 2009; 15:539-541.
    View PubMed
  44. Vilariño-Güell C, Chai H, Keeling BH, Young JE, Rajput A Lynch T, Aasly JO, Uitti RJ, Wszolek ZK, Farrer MJ, Lin S-C. MEIS1 p.R272H in familial restless legs syndrome. Neurology 2009; 73:243-245.
    View PubMed
  45. Wider C, Lincoln S, Dachsel JC, Kapatos G, Heckman MG, Diehl NN, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Dickson DW, Wszolek ZK, Farrer MJ. GCH1 expression in human cerebellum from healthy individuals is not gender dependent. Neurosci Lett 2009; 462:73-75.
    View PubMed
  46. Puschmann A, Wszolek ZK, Farrer M, Gustafson L, Widner H, Nilsson C. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus? Parkinsonism Relat Disord 2009; 15:390-392.
    View PubMed
  47. Slowinski JL, Schweitzer KJ, Imamura A, Uitti RJ, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. Brainstem atrophy on routine MR study in pallidopontonigral degeneration. J Neurol 2009; 256:827-829.
    View PubMed
  48. Wider C, Dickson DW, Schweitzer KJ, Broderick DF, Wszolek ZK. Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation. J Neurol 2009; 256:839-842.
    View PubMed
  49. Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD). A single entity? Neurology 200959 2009; 72:1953-1959.
    View PubMed
  50. Sitek EJ, Narożańska E, Sławek J, Wieczorek D, Brockhuis B, Lass P, Dubaniewicz M, Jasińska-Myga B, Baker M, Rademakers R, Wszolek Z. Unilateral neglect in a patient diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17. Acta Neuropsych 2009; 21:209-210.
    View PubMed
  51. Gałązka-Friedman J, Bauminger ER, Szlachta K, Schweitzer K, Wszolek Z, Dickson D, Friednman A. Mössbauer studies of pathological brain tissues affected by PSP disease. Acta Physica Polonica 2009; 115:545-547.
    View PubMed
  52. Krygowska-Wajs A, Cheshire WP Jr, Wszolek ZK, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, Moskala M, Sowa-Staszczak. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord 2009; 15:692-696.
    View PubMed
  53. Puschmann A, Ross OA, Vilariño-Güell C, Lincoln SJ, Kachergus JM, Cobb SA, Lindquist SG, Nielsen JE, Wszolek ZK, Farrer M, Widner H, van Western D, Hägerström D, Markopoulou K, Chase BA, Nilsson K, Reimer J, Nilsson C. A Swedish family with de novo α–synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat Disord 2009; 15:627-632.
    View PubMed
  54. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008 Dec 1; 17(23):3631-42. Epub 2008 Aug 21.
    View PubMed
  55. Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ. Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 2008 Nov 25; 71(22):1790-5.
    View PubMed
  56. Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ. Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 2008 Nov 25; 71(22):1790-5.
    View PubMed
  57. Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilariño-Güell, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine β–hydroxylase –1021C>T association and Parkinson’s disease Parkinsonism Relat Disord 2008 Nov; 14(7):544-7 Epub 2008 Aug 22.
    View PubMed
  58. Ross OA, Soto AI, Vilarino-Guell C, Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord 2008 Nov; 14(7):539-43. Epub 2008 Sep 14.
    View PubMed
  59. Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilarino-Guell C, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Parkinsonism Relat Disord 2008 Nov; 14(7):544-7. Epub 2008 Aug 22.
    View PubMed
  60. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 2008 Sep 16; 71(12):925-9.
    View PubMed
  61. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 2008 Sep 16; 71(12):925-9.
    View PubMed
  62. Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S, Parkinson Study Group ELLDOPA Investigators. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 2008 Aug 12; 71(7):481-5.
    View PubMed
  63. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental lewy body disease and preclinical Parkinson disease. Arch Neurol 2008 Aug; 65(8):1074-80.
    View PubMed
  64. Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D, Wszolek ZK, Vingerhoets FJG. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism & Related Disorders 2008 Aug; 14(6):465-70.
    View PubMed
  65. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 2008 Aug; 65(8):1074-80.
    View PubMed
  66. Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D, Wszolek ZK, Vingerhoets FJ. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism Relat Disord 2008 Aug; 14(6):465-70. Epub 2008 Mar 14.
    View PubMed
  67. Vilarino-Guell C, Soto AI, Young JE, Lin SC, Uitti RJ, Wszolek ZK, Farrer MJ. Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology 2008 Jul 15; 71(3):222-3.
    View PubMed
  68. Vilariño-Güell C, Soto AI, Young JE, Lin S-C, Uitti RJ, Wszolek ZK, Farrer MJ. Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology 2008 jul 15; 71(3):222-3.
    View PubMed
  69. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008 Jul; 7(7):583-590. Epub 2008 Jun 06.
    View PubMed
  70. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008 Jul; 67(7):649-56.
    View PubMed
  71. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008 Jul; 67(7):649-56. Epub 2008 Jun 24.
    View PubMed
  72. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AHV, Lynch T, Bhatia KP, Gasser T, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurology 2008 Jul; 7(7):583-90.
    View PubMed
  73. Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, Stansbury MS, Chase BA. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease. Acta Neuropathol 2008 Jul; 116(1):25-35. Epub 2008 Apr 04.
    View PubMed
  74. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008 Jul; 7(7):583-90. Epub 2008 Jun 06.
    View PubMed
  75. Wider C, Uitti RJ, Wszolek ZK, Fang JY, Josephs KA, Baker MC, Rademakers R, Hutton ML, Dickson DW. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov Disord 2008 Jun 15; 23(8):1168-73.
    View PubMed
  76. Wider C, Uitti RJ, Wszolek ZK, Fang JY, Josephs KA, Baker MC, Rademakers R, Hutton ML, Dickson DW. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov Disord 2008 Jun 15; 23(8):1168-73.
    View PubMed
  77. Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, De Deyn PP, Engelborghs S, Pickut B, Uitti RJ Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008 Apr 15; 70(16 Pt 2):1456-60. Epub 2008-03-12.
    View PubMed
  78. Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, Hutton M, Farrer MJ, Wszolek ZK, Vingerhoets FJ. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008 Apr 15; 70(16 Pt 2):1377-83. Epub 2007-09-05.
    View PubMed
  79. Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, De Deyn PP, Engelborghs S, Pickut B, Uitti Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008 Apr 15; 70(16 Pt 2):1456-60. Epub 2008 Mar 12.
    View PubMed
  80. Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, Hutton M, Farrer MJ, Wszolek ZK, Vingerhoets FJ. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008 Apr 15; 70(16 Pt 2):1377-83. Epub 2007 Sep 05.
    View PubMed
  81. Imamura A, Geda YE, Slowinski J, Wszolek ZK, Brown LA, Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol 2008 Apr; 15(4):350-4. Epub 2008 Feb 26.
    View PubMed
  82. Imamura A, Geda YE, Slowinski J, Wszolek ZK, Brown LA, Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol 2008 Apr; 15(4):350-4. Epub 2008-02-26.
    View PubMed
  83. Tsuboi Y, Dickson DW, Nabeshima K, Schmeichel AM, Wszolek ZK, Yamada T, Benarroch EE. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol 2008 Feb; 115(2):263-8. Epub 2007 Jun 19.
    View PubMed
  84. Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008 Jan; 255(1):37-44. Epub 2007-12-19.
    View PubMed
  85. Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008 Jan; 255(1):37-44. Epub 2007 Dec 19.
    View PubMed
  86. Wider C, Wszolek ZK. Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies. Neurodegener Dis 2008; 5:122-125.
    View PubMed
  87. Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, Stansbury MS, Chase BA. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease. Variability in familial Parkinson’s disease Acta Neuropathol 2008; 116:25-35.
    View PubMed
  88. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Jospehs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkisnon disease. Arch Neurol 2008; 65:1074-1080.
    View PubMed
  89. Schifitto G, Friedman JH, Oakes D, Schulman L, Comella CL, Marek K, Fahn S, The Parkinson Study Group ELLDOPA Investigators. Fatigue in levodopa-naïve subjects with Parkinson disease. Neurology 2008; 71:481-5.
    View PubMed
  90. Wider C, Uitti RJ, Wszolek ZK, Fang JY, Jospephs KA, Baker MC, Rademakers R, Hutton ML, Dickson DW. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov Disord 2008; 23:1168-1173.
    View PubMed
  91. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Peterson RC, Prisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008; 67:649-656.
    View PubMed
  92. Ross OA, Soto AI, Vilariño-Güell C, Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Genetic variation of Omi/HtrA2 and Parkinson’s disease Parkinsonism Relat Disord 2008; 14:539-543.
    View PubMed
  93. Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilariño-Güell, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine β–hydroxylase –1021C>T association and Parkinson’s disease Parkinsonism Relat Disord 2008; 14:544-547.
    View PubMed
  94. Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephen DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, Hutton M, Farrer MJ, Wszolek ZK, Vingerhoets FJG. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1. Redefining DYT14 as DYT5 Neurology (editorial page 1373) 2008; 70:1377-1383.
    View PubMed
  95. Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan E-K, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, Paul De Deyn P, Engelborghs S, Pickut B, Uit Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008; 70:1456-60.
    View PubMed
  96. Wider C, Wszolek ZK. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature review. Parkinsonism Relat Disord 2008; 14(1):1-7. Epub 2007 Sep 17.
    View PubMed
  97. Wider C, Wszolek ZK. Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies. Neurodegener Dis 2008; 5(3-4):122-5. Epub 2008 Mar 06.
    View PubMed
  98. Tsuboi Y, Dickson DW, Nabeshima K, Schmeichel AM, Wszolek ZK, Yamada T, Benarroch EE. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol 2008; 115:263-268.
    View PubMed
  99. Wider C, Wszolek ZK. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome) – a literature review. Parkinsonism Relat Disord 2008; 14:1-7.
    View PubMed
  100. Slowinski J, Imamura A, Uitti RJ, Polley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255:37-44.
    View PubMed
  101. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008; 4(9):e1000193. Epub 2008 Sep 19.
    View PubMed
  102. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007 Nov; 130(Pt 11):2770-88. Epub 2007 Apr 05.
    View PubMed
  103. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007 Apr 02.
    View PubMed
  104. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007-04-02.
    View PubMed
  105. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, Wood EM, Yu CE, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schofield PR, Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol 2007 Oct; 10(6):857-68.
    View PubMed
  106. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, Wood EM, Yu CE, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schofield PR, Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol 2007 Oct; 6(10):857-68.
    View PubMed
  107. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007 Apr 02.
    View PubMed
  108. Miklossy J, Qing H, Guo JP, Yu S, Wszolek ZK, Calne D, McGeer EG, McGeer PL. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Acta Neuropathol (Berl) 2007 Sep; 114(3):243-54. Epub 2007 Jul 17.
    View PubMed
  109. Bogaerts V, Engelborghs S, Kumar-Singh S, Goossens D, Pickut B, van der Zee J, Sleegers K, Peeters K, Martin JJ, Del-Favero J, Gasser T, Dickson DW, Wszolek ZK, De Deyn PP, Theuns J, Van Broeckhoven C. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 2007 Sep; 130(Pt 9):2277-91. Epub 2007 Aug 06.
    View PubMed
  110. Haugarvoll K, Wszolek ZK, Hutton M. The genetics of frontotemporal dementia. Neurol Clin 2007 Aug; 25(3):697-715, vi.
    View PubMed
  111. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: Phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007 Aug; 13(6):333-9. Epub 2007 Feb 08.
    View PubMed
  112. Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW, Farrer MJ. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 2007 Jul 29; 147(4):1047-58. Epub 2007 Jul 03.
    View PubMed
  113. Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delledonne A, Dickson DW, Farrer MJ. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 2007 Jul 29; 147(4):1047-58. Epub 2007-07-03.
    View PubMed
  114. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm 2007 Jul; 114(7):947-50. Epub 2007 Feb 23.
    View PubMed
  115. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord 2007 May; 13(4):230-9 Epub 2006 Dec 29.
    View PubMed
  116. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 2007 Apr 4; 27(14):3650-62.
    View PubMed
  117. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 2007 Apr; 80(4):769-78. Epub 2007 Mar 08.
    View PubMed
  118. Baba Y, Uitti RJ, Boylan KB, Uehara Y, Yamada T, Farrer MJ, Couchon E, Batish SD, Wszolek ZK. Aprataxin (APTX) gene mutations resembling multiple system atrophy. Parkinsonism Relat Disord 2007 Apr; 13(3):139-42.
    View PubMed
  119. Taylor JP, Hulihan MM, Kachergus JM, Melrose HL, Lincoln SJ, Hinkle KM, Stone JT, Ross OA, Hauser R, Aasly J, Gasser T, Payami H, Wszolek ZK, Farrer MJ. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics 2007 Apr; 8(2):95-102. [Epub 2007-01-16]
    View PubMed
  120. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, L Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 2007 Apr; 80(4):769-78.
  121. Taylor JP, Hulihan MM, Kachergus JM, Melrose HL, Lincoln SJ, Hinkle KM, Stone JT, Ross OA, Hauser R, Aasly J, Gasser T, Payami H, Wszolek ZK, Farrer MJ. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics 2007 Apr; 8(2):95-102. Epub 2007 Jan 16.
    View PubMed
  122. Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ. ELAVL4, PARK10, and the Celts. Mov Disord 2007 Mar 15; 22(4):585-7.
    View PubMed
  123. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007 Mar 13; 68(11):812-9.
    View PubMed
  124. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VMY, Leverenz JB, Masliah DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007 Mar; 68(11):812-9.
    View PubMed
  125. Whittle AJ, Ross OA, Naini A, Gordon P, Mistumoto H, Dachsel JC, Stone JT, Wszolek ZK, Farrer MJ, Przedborski S. Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis. J Neural Transm 2007 Mar; 114(3):327-9.
    View PubMed
  126. Frank AR, Wszolek ZK, Jack CR Jr, Boeve BF. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology 2007 Feb 20; 68(8):620-1.
    View PubMed
  127. Slowinski J, Dominik J, Uitti RJ, Ahmed Z, Dickson DD, Wszolek ZK. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology 2007 Feb; 27(1):73-80.
    View PubMed
  128. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin S-C, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord 2007; 13:230-239.
    View PubMed
  129. Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, Delldonne A, Dickson DW, Farrer MJ. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 2007; 147:1047-1058 (Cover page picture).
    View PubMed
  130. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM-Y, Leverenz JB, Maslia DLB and PDD boundary issues. Diagnosis treatment, molecular pathology, and biomarkers. Neurology 2007; 68:812-819.
  131. Baba Y, Uitti RJ, Boylan KB, Uehara Y, Yamada T, Farrer MJ, Couchon E, Batish SV, Wszolek ZK. Aprataxin (APTX) gene mutations resembling multiple system atrophy. Parkinsonism Relat Disord 2007; 13:139-42.
  132. Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ. ELAVL4, PARK10, and the Celts. Mov Disord 2007; 22:585-7.
  133. Miklossy J, Qing H, Guo J-P, Yu S, Wszolek ZK, Calne D, McGeer EG, McGeer PL. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Acta Neuropathol 2007; 114:243-254.
    View PubMed
  134. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007; 13:333-9.
    View PubMed
  135. Bogaerts V, Engelborghs S, Kumar-Singh S, Goossens D, Pickut B, van der Zee J, Sleegers K, Peeters K, Martin J-J, Del-Favero J, Gasser T, Dickson DW, Wszolek ZK, De Deyn PP, Theuns J, Van Broeckhoven C. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 2007; 130:2277-2291.
    View PubMed
  136. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, MomeniP, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung G-Y, Kelley B, Kuntz K, Steinbart E, McCarthy Wood E, Yu C-E, Josephs K, Sorenson E, Womack KB, Weintraub S, Pickering-Brown SM, Schof Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C?¨T (Arg493X) mutation: an international initiative. Lancet Neurol 2007; 6:857-868.
    View PubMed
  137. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK. Clinical and genetic features of families with frontotemporal dementia and parkinsonism liked to chromosome 17 with P301S tau mutation. J Neural Transm 2007; 114:947-950.
    View PubMed
  138. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin S-C, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130:2770-88.
    View PubMed
  139. Wider C, Wszolek ZK. Clinical genetics of Parkinson’s disease and related disorders. Parkinsonism Relat Disord 2007; 13(Suppl 3):S229-S232.
    View PubMed
  140. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Gibson JM, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders 2007; 13(7):386-8.
    View PubMed
  141. Wider C, Wszolek ZK. Clinical genetics of Parkinson's disease and related disorders. Parkinsonism Relat Disord 2007; 13 Suppl 3:S229-32.
    View PubMed
  142. Ross OA, Haugarvoll K, Stone JA, Heckman MG, White LR, Aasly JO, Gibson JM, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders 2007; 13(7):386-8.
    View PubMed
  143. Frank AR, Wszolek ZK, Jack CR Jr, Boeve BF. Distinctive MRI findings in pallido-ponto-nigral degeneration (PPND). Neurology 2007; 68:620-621.
  144. Chabolla DR, Wszolek ZK. Pharmacologic management of seizures in organ transplant. Neurology 2006 Dec 26; 67(12 Suppl 4):S34-8.
    View PubMed
  145. Imamura A, Uitti RJ, Wszolek ZK. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord 2006 Dec; 12(8):506-8. Epub 2006 May 24.
    View PubMed
  146. Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol 2006 Dec; 20(4):623-36.
    View PubMed
  147. Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 2006 Nov; 77(11):1235-7.
    View PubMed
  148. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006 Oct 15; 15(20):2988-3001.
    View PubMed
  149. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006 Oct 15; 15(20):2988-3001. Epub 2006 Sep 01.
    View PubMed
  150. Baba Y, Putzke JD, Tsuboi Y, Josephs KA, Thomas N, Wszolek ZK, Dickson DW. Effect of MAPT and APOE on prognosis of progressive supranuclear palsy. Neurosci Lett 2006 Sep 11; 405(1-2):116-9. Epub 2006 Jul 12.
    View PubMed
  151. Brodkin CL, Wszolek ZK. Neurologic presentation of Erdheim-Chester disease. Neurol Neurochir Pol 2006 Sep-Oct; 40(5):397-403.
    View PubMed
  152. Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Durr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 2006 Sep; 63(9):1250-4.
    View PubMed
  153. Wszolek ZK, Baba Y, Mackenzie IR, Uitti RJ, Strongosky AJ, Broderick DF, Baker MC, Melquist S, Hutton ML, Tsuboi Y, Allanson JE, Carr J, Kumar A, Calne SM, Miklossy J, McGeer PL, Calne DB, Stoessl AJ. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology 2006 Aug 22; 67(4):620-5.
    View PubMed
  154. Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, Tian J, Bigio EH, Ghetti B, Murrell JR, Delisle MB, Mirra S, Crain B, Zolo P, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Khan N, Ravid R, Dickson D, Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropathol Appl Neurobiol 2006 Aug; 32(4):374-87.
    View PubMed
  155. Liss JM, Krein-Jones K, Wszolek ZK, Caviness JN. Speech characteristics of patients with pallido-ponto-nigral degeneration and their application to presymptomatic detection in at-risk relatives. Am J Speech Lang Pathol 2006 Aug; 15(3):226-35.
    View PubMed
  156. Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, Tian J, Bigio EH, Ghetti B, Murrell JR, Delisle MB, Mirra S, Crain B, Zolo P, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, Mackenzie J, Khan N, Ravid R, Dickson D, Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropathol Appl Neurobiol 2006 Aug; 32(4):374-87.
    View PubMed
  157. Haugarvoll K, Wszolek ZK. PARK8 LRRK2 parkinsonism. Curr Neurol Neurosci Rep 2006 Jul; 6(4):287-94.
    View PubMed
  158. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort. Mov Disord 2006 May; 21(5):689-92.
    View PubMed
  159. Hirano S, Shinotoh H, Kobayashi T, Tsuboi Y, Wszolek ZK, Aotsuka A, Tanaka N, Ota T, Fukushi K, Tanada S, Irie T. Brain acetylcholinesterase activity in FTDP-17 studied by PET. Neurology 2006 Apr 25; 66(8):1276-7.
    View PubMed
  160. Baba Y, Markopoulou K, Putzke JD, Whaley NR, Farrer MJ, Wszolek ZK, Uitti RJ. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol 2006 Apr; 63(4):579-83.
    View PubMed
  161. Baba Y, Ghetti B, Baker MC, Uitti RJ, Hutton ML, Yamaguchi K, Bird T, Lin W, DeLucia MW, Dickson DW, Wszolek ZK. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 2006 Apr; 111(4):300-11. Epub 2006 Mar 08.
    View PubMed
  162. de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian JZ, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Holton J, An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. Acta Neuropathol (Berl) 2006 Apr; 111(4):329-40.
    View PubMed
  163. de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Holton J, An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 2006 Apr; 111(4):329-40. Epub 2006 Mar 22.
    View PubMed
  164. Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006 Mar; 14(3):322-31.
    View PubMed
  165. Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006 Mar; 14(3):322-31.
    View PubMed
  166. Boeve BF, Lin SC, Strongosky A, Dickson DW, Wszolek ZK. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol 2006 Feb; 63(2):268-72.
    View PubMed
  167. Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Lrrk2 and Lewy body disease. Ann Neurol 2006 Feb; 59(2):388-93.
    View PubMed
  168. Mata IF, Bodkin CL, Adler CH, Lin SC, Uitti RJ, Farrer MJ, Wszolek ZK. Genetics of restless legs syndrome. Parkinsonism Relat Disord 2006 Jan; 12(1):1-7.
    View PubMed
  169. Liss JM, Krein-Jones K, Wszolek ZK, Caviness JN. Speech characteristics of patients with pallido-ponto-nigral degeneration and their application to presymptomatic detection in at-risk relatives. Am J Speech Lang Pathol 2006; 15:226-235.
    View PubMed
  170. Ishihara L, Warren L, Gibson R, Amouri R, Leasage S, Durr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F. Clinical features of Parkinson?s disease patients homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 2006; 63:1250-1254.
    View PubMed
  171. Wszolek ZK, Tsuboi Y, Ghetti B, Pickering-Brown S, Baba Y, Cheshire WP. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTPD-17). Orphanet J Rare Dis 2006; 1:1-9.
    View PubMed
  172. Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl 2006; (70):221-9.
    View PubMed
  173. Uitti RJ, Wszolek ZK. Concerning neuroprotective therapy for Parkinson's disease. J Neural Transm Suppl 2006; (70):433-7.
    View PubMed
  174. Klodowska-Duda G, Slowinski J, Opala G, Gorzkowska A, Jasinska-Myga B, Wszolek ZK, Dickson DW. Corticobasal degeneration -- clinico-pathological considerations. Folia Neuropathol 2006; 44(4):257-64.
    View PubMed
  175. Wszolek ZK, Tsuboi Y, Ghetti B, Pickering-Brown S, Baba Y, Cheshire WP. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Orphanet J Rare Dis 2006; 1:30. Epub 2006 Aug 09.
    View PubMed
  176. Slowinski J, Wszolek ZK. Report on World Parkinson Congress. [Polish]. Neurol Neurochir Pol 2006; 40(3):258-9.
    View PubMed
  177. Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005 Dec; 6(4):171-7.
    View PubMed
  178. Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 2005 Dec; 128(Part 12):2777-85.
    View PubMed
  179. Krygowska-Wajs A, Kachergus JM, Hulihan MM, Farrer MJ, Searcy JA, Booij J, Berendse HW, Wolters ECh, Wszolek ZK. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism. J Neural Transm 2005 Nov; 112(11):1487-502. Epub 2005 Mar 23.
    View PubMed
  180. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson's disease phenotype. J Neurol 2005 Oct; 252(10):1201-5.
    View PubMed
  181. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, Gasser T, Wszolek Z, Muller T, Bornemann A, Wolburg H, Downward J, Riess O, Schulz JB, Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005 Aug 1; 14(15):2099-111.
    View PubMed
  182. Baba Y, Hentschel K, Freeman WD, Broderick DF, Wszolek ZK. Large paraspinal and iliopsoas muscle hematomas. Archives of Neurology 2005 Aug; 62(8):1306.
    View PubMed
  183. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease - Handedness predicts asymmetry. Neurology 2005 Jun 14; 64(11):1925-30.
    View PubMed
  184. Miklossy J, Mackenzie IR, Dorovini-Zis K, Calne DB, Wszolek ZK, Klegeris A, McGeer PL. Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathol (Berl) 2005 Jun; 109(6):643-53.
    View PubMed
  185. Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, Farrer M, Putzke JD, Woodruff BK, Ghetti B, Murrell JR, Boeve BF, Petersen RC, Verpillat P, Brice A, Delisle MB, Rascol O, Arima K, Dysken MW, Yasuda M, Kobayashi T, Sunohara N, Komure O, Kuno The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord 2005 Jun; 11(4):205-8.
    View PubMed
  186. Putzke JD, Uitti RJ, Obwegeser AA, Wszolek ZK, Wharen RE. Bilateral thalamic deep brain stimulation: midline tremor control. J Neurol Neurosurg Psychiatry 2005 May; 76(5):684-90.
    View PubMed
  187. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord 2005 May; 11(3):139-45.
    View PubMed
  188. Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord 2005 May; 11(3):147-50.
    View PubMed
  189. Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc 2005 May; 80(5):641-51.
    View PubMed
  190. Josephs KA, Uchikado H, McComb RD, Bashir R, Wszolek Z, Swanson J, Matsumoto J, Shaw G, Dickson DW. Extending the clinicopathological spectrum of neurofilament inclusion disease. Acta Neuropathol (Berl) 2005 Apr; 109(4):427-32.
    View PubMed
  191. Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations. Am J Hum Genet 2005 Apr; 76(4):672-80.
    View PubMed
  192. Eriksen JL, Wszolek Z, Petrucelli L. Molecular pathogenesis of Parkinson disease. Arch Neurol 2005 Mar; 62(3):353-7.
    View PubMed
  193. Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ. Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord 2005 Feb; 20(2):230-3.
    View PubMed
  194. Cheshire WP, Wszolek ZK. Body mass index is reduced early in Parkinson's Disease. Parkinsonism & Related Disorders 2005 Jan; 11(1):35-8.
    View PubMed
  195. Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 2005; 11(8):493-8.
    View PubMed
  196. Wszolek ZK, Slowinski J, Golan M, Dickson DW. Frontotemporal dementia and parkinsonism linked to chromosome 17. Folia Neuropathol 2005; 43(4):258-70.
    View PubMed
  197. Berg D, Schweitzer KJ, Leitner P, Zimprich A, Lichtner P, Belcredi P, Brüssel T, Schulte C, Maass S, Nägele T, Wszolek ZK, Gasser T. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson’s disease. Brain 2005; 128:3000-3011.
    View PubMed
  198. Oliveira JRM, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, Gilbert J, Wszolek ZK, Calne DB, Stoessl AJ, Hutton M, Manyam BV, Boller F, Baquero M, Geschwind DH. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 2004 Dec 14; 63(11):2165-7.
    View PubMed
  199. Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Is the neuropathological 'gold standard' diagnosis dead? - Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder. Parkinsonism Relat Disord 2004 Dec; 10(8):461-3.
    View PubMed
  200. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004 Nov 18; 44(4):601-7.
    View PubMed
  201. Putzke JD, Wharen RE, Obwegeser AA, Wszolek ZK, Lucas JA, Turk MF, Uitti RJ. Thalamic deep brain stimulation for essential tremor: Recommendations for long-term outcome analysis. Can J Neurol Sci 2004 Aug; 31(3):333-42.
    View PubMed
  202. Woodruff BK, Baba Y, Hutton ML, Wszolek ZK, Tsuboi Y, Kobayashi T, Ghetti B, Arima K, Yasuda M, Rascol O. Haplotype-phenotype correlations in kindreds with the N279K mutation in the tau gene. Arch Neurol 2004 Aug; 61(8):1327.
    View PubMed
  203. Kumar A, Calne SM, Schulzer M, Mak E, Wszolek Z, Van Netten C, Tsui JKC, Stoessl AJ, Calne DB. Clustering of Parkinson disease - Shared cause or coincidence? Arch Neurol 2004 Jul; 61(7):1057-60.
    View PubMed
  204. Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, Singleton A, Bower J, Utti RJ, Bird TD, de la Fuente-Femandez R, Tsuboi Y, Klimek ML, Suchowersky O, Hardy J, Calne DB, Wszolek ZK, Farrer M, Gwinn-Hardy K, Stoessl AJ. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 2004 Jun; 19(6):622-9.
    View PubMed
  205. Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Muller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004 May 11; 62(9):1619-22.
    View PubMed
  206. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004 Feb; 55(2):174-9.
    View PubMed
  207. Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T. The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004 Jan; 74(1):11-9.
    View PubMed
  208. The Parkinson Study Group. Levodopa and the progression of Parkinson?s disease. N Engl J Med 2004; 351:2498-2508.
    View PubMed
  209. Kumar A, Calne SM, Schulzer M, Mak E, Wszolek Z, Van Netten C, Tsui JKC, Stoessl AJ, Calne DB. Clustering of Parkinson disease. Arch Neurol 2004; 61:1057-1060.
    View PubMed
  210. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351:2498-2508.
    View PubMed
  211. Putzke JD, Wharen RE, Wszolek ZK, Turk MF, Strongosky AJ, Uitti RJ. Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. Parkinsonism & Related Disorders 2003 Dec; 10(2):81-8.
    View PubMed
  212. Furtado S, Pfeiffer RF, Uitti RJ, Wszolek ZK. Neurotherapeutics and movement disorders. World Federation of Neurology 2003 Nov 9.
  213. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon 4. Neuropathology & Applied Neurobiology 2003 Oct; 29(5):503-10.
    View PubMed
  214. Tsuboi Y, Slowinski J, Josephs A, Honer WG, Wszolek ZK, Dickson DW. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003 Jun 10; 60(11):1766-9.
    View PubMed
  215. Ferman TJ, McRae CA, Arvanitakis Z, Tsuboi Y, Vo A, Wszolek ZK. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Parkinsonism & Related Disorders 2003 Jun; 9(5):265-70.
    View PubMed
  216. Slowinski J, Wharen RE, Uitti RJ, Wszolek ZK, Krygowska-Wajs A, Mrowka R. [Current therapies for parkinson's disease. Part II: surgical treatment] [Article in Polish] Neurol Neurochir Pol 2003 May-Jun; 37(3):677-86.
    View PubMed
  217. Krygowska-Wajs A, Hussey JM, Hulihan M, Farrer MJ, Tsuboi Y, Uitti RJ, Wszolek ZI. Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci. Parkinsonism & Related Disorders 2003 Mar; 9(4):193-200.
    View PubMed
  218. Tsuboi Y, Wszolek ZK, Mizuno Y, Kobayashi T, Yasuda M, Yamada T. Japanese contribution to the understanding of frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). Brain & Nerve (Tokyo) 2003 Feb; 55(2):107-19.
    View PubMed
  219. Wszolek ZK, Krygowska-Wajs A, Barcikowska M. [Fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): clinical criteria]. [Polish]. Neurol Neurochir Pol 2003 Jan-Feb; 37(1):173-84.
    View PubMed
  220. Kobayashi H, Kruger R, Markopoulou K, Wszolek Z, Chase B, Taka H, Mineki R, Murayama K, Riess O, Mizuno Y, Hattori N. Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease. Brain 2003 Jan; 126(Part 1):32-42.
    View PubMed
  221. Caviness JN, Tsuboi Y, Wszolek ZK. Clinical-electrophysiological correlation of tremor and myoclonus in a kindred with the N279K tau mutation. Parkinsonism & Related Disorders 2003 Jan; 9(3):151-7.
    View PubMed
  222. Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML. Hereditary tauopathies and parkinsonism. Adv Neurol 2003; 91:153-63.
    View PubMed
  223. Uitti RJ, Wszolek ZK. Dopamine agonists, sleep disorders, and driving in Parkinson's disease. Adv Neurol 2003; 91:343-9.
    View PubMed
  224. Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, Soulages X, Murrell JR, Ghetti B, Yasuda M, Komure O, Kuno S, Arima K, Sunohara N, Kobayashi T, Mizuno Y, Wszolek ZK. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology 2002 Dec 10; 59(11):1791-3.
    View PubMed
  225. Uitti RJ, Tsuboi Y, Pooley RA, Putzke JD, Turk MF, Wszolek ZK, Witte RJ, Wharen RE. Magnetic resonance imaging and deep brain stimulation. Neurosurgery 2002 Dec; 51(6):1423-8.
    View PubMed
  226. Cheshire WP, Tsuboi Y, Wszolek ZK. Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17. Auton Neurosci 2002 Nov 29; 102(1-2):71-7.
    View PubMed
  227. Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernandez R, Hussey J, Lockhart P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek ZK. SCA-2 presenting as parkinsonism in an Alberta family - Clinical, genetic, and PET findings. Neurology 2002 Nov 26; 59(10):1625-7.
    View PubMed
  228. Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation - A comparison of the pallidopontonigral degeneration kindred and a French family. Arch Neurol 2002 Jun; 59(6):943-50.
    View PubMed
  229. Tsuboi Y, Wszolek ZK, Kusuhara T, Doh-ura K, Yamada T. Japanese family with parkinsonism, depression, weight loss, and central hypoventilation. Neurology 2002 Apr 9; 58(7):1025-30.
    View PubMed
  230. Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol (Berl) 2002 Apr; 103(4):344-50.
    View PubMed
  231. Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3. Gene 2002 Feb 20; 285(1-2):229-37.
    View PubMed
  232. Farrer M, Hardy J, Hutton M, Maraganore D, Tsuboi Y, Wszolek ZK. Identifying genetic factors in Parkinson disease. JAMA 2002 Feb 13; 287(6):715.
    View PubMed
  233. Hussey J, Lockhart PJ, Seltzer W, Wszolek ZK, Payami H, Hanson M, Gwinn-Hardy K, Farrer M. Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats. Genet Test 2002 Fal; 6(3):217-20.
    View PubMed
  234. Pal PK, Wszolek ZK, Uitti R, Markopoulou K, Calne SM, Stoessl AJ, Calne DB. Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes. Parkinsonism & Related Disorders 2001 Sep; 8(1):51-56.
    View PubMed
  235. West AB, Zimprich A, Lockhart PJ, Farrer M, Singleton A, Holtom B, Lincoln S, Hofer A, Hill L, Muller-Myhsok B, Wszolek ZK, Hardy J, Gasser T. Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur J Hum Genet 2001 Sep; 9(9):659-666.
    View PubMed
  236. Wszolek ZK, Tsuboi Y, Uitti RJ, Reed L, Hutton ML, Dickson DW. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. Brain 2001 Aug; 124(Pt 8):1666-70.
    View PubMed
  237. Arvanitakis Z, Wszolek ZK. Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol 2001 Aug; 14(4):491-7.
    View PubMed
  238. Wszolek ZK, Kardon RH, Wolters EC, Pfeiffer RF. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration. Mov Disord 2001 Jul; 16(4):756-60.
    View PubMed
  239. Wszolek ZK, Chabolla DR, Rubino FA. Nonconvulsive status epilepticus in a patient with mental status changes. Am J Electroneurodiagn Technol 2001 Jun; 41(2):136-141.
  240. Pal PK, Wszolek ZK, Kishore A, de la Fuente-Fernandez R, Sossi V, Uitti RJ, Dobko T, Stoessl AJ. Positron emission tomography in Pallido-Ponto-Nigral degeneration (PPND) family (frontotemporal dementia with Parkinsonism linked to chromosome 17 and point mutation in Tau gene). Parkinsonism & Related Disorders 2001 Apr; 7(2):81-88.
    View PubMed
  241. McRae CA, Diem G, Yamazaki TG, Mitek A, Wszolek ZK. Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17. Eur J Neurol 2001 Mar; 8(2):179-83.
    View PubMed
  242. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001 Jan-Feb; 22(1):89-107.
    View PubMed
  243. Zink M, Grimm L, Wszolek ZK, Gasser T. Autosomal-dominant Parkinson's disease linked to 2p13 is not caused by mutations in transforming growth factor alpha (TGF alpha). J Neural Transm 2001; 108(8-9):1029-1034.
    View PubMed
  244. Wszolek ZK, Uitti RJ, Markopoulou K. Familial Parkinson's disease and related conditions - Clinical genetics. Adv Neurol 2001; (86):33-43.
  245. Uitti RJ, Wharen RE, Duffy JR, Lucas JA, Schneider SL, Rippeth JD, Wszolek ZK, Obwegeser AA, Turk MF, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: speech, motor, and neuropsychological outcome measurements. Parkinsonism & Related Disorders 2000 Jul; 6(3):133-143.
    View PubMed
  246. Lynch HT, McComb RD, Osborn NK, Wolpert PA, Lynch JF, Wszolek ZK, Sidransky D, Steg RE. Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred, including a case of Sturge-Weber syndrome. Cancer 2000 Jan 15; 88(2):433-9.
    View PubMed
  247. Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E, Calne DB, Stoessl AJ. PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology 1999 Dec 10; 53(9):2097-102.
    View PubMed
  248. Wszolek ZK, Markopoulou K. Molecular genetics of familial Parkinsonism. Parkinsonism & Related Disorders 1999 Dec; 5(4):145-155.
  249. Steg RE, Kessinger A, Wszolek ZK. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 1999 May; 23(9):959-62.
    View PubMed
  250. Uitti RJ, Wszolek ZK. Medical treatment of Parkinson's disease. Neurosci News 1999; 2(3-4):36-43.
  251. Wszolek ZK, Uitti RJ. The clinical genetics of Parkinson's disease. Neurosci News 1999; 2(3-4):66-72.
  252. Wszolek ZK, Koller WC. Rare and unusual parkinsonian syndromes. Adv Neurol 1999; 80:369-76.
    View PubMed
  253. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA. Reduced expression of the G209A β-synuclein allele in familial parkinsonism. Ann Neurol 1999; 46:374-81.
    View PubMed
  254. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, Lee VM. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998 Dec 4; 282(5395):1914-7.
    View PubMed
  255. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 1998 Oct 27; 95(22):13103-7.
    View PubMed
  256. Wszolek ZK, Lagerlund TD, Steg RE, McManis PG. Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroencephalography & Clinical Neurophysiology 1998 Sep; 107(3):213-22.
    View PubMed
  257. Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VM, Trojanowski JQ, Schelper RL. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration"). Journal of Neuropathology & Experimental Neurology 1998 Jun; 57(6):588-601.
    View PubMed
  258. Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, Agid Y, Bonifati V, Demichele G, Volpe G, Lincoln S, Breteler M, Meco G, Brice A, Marsden CD, Hardy J, Wood NW. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's-disease fails to reveal any further mutations. Hum Mol Genet 1998 Apr; 7(4):751-753.
    View PubMed
  259. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998 Mar; 18(3):262-5.
    View PubMed
  260. Wszolek ZK, Markopoulou K. Olfactory dysfunction in Parkinson's disease. Clin Neurosci 1998; 5(2):94-101.
    View PubMed
  261. Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK. Olfactory dysfunction in familial parkinsonism. Neurology 1997 Nov; 49(5):1262-7.
    View PubMed
  262. Denson MA, Wszolek ZK, Pfeiffer RF, Wszolek EK, Paschall TM, McComb RD. Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol 1997 Oct; 42(4):638-43.
    View PubMed
  263. Wszolek ZK, Steg RE, Armitage JO. Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997 Mar; 19(6):637-8.
    View PubMed
  264. Wszolek ZK, Steg RE. Seizures after orthotopic liver transplantation. Seizure 1997 Feb; 6(1):31-9.
    View PubMed
  265. Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D'Amato JC, Gilman S, Wszolek Z, et al. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41:706-715.
    View PubMed
  266. Wszolek ZK, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, Berry K, Calne DB, Vingerhoets FJG, Klein C, Pfeiffer RF. German-Canadian family (family A) with Parkinsonism, amyotrophy, and dementia - longitudinal observations. Parkinsonism & Related Disorders 1997; 3:125-139.
  267. Soria ED, Conrad DE, Wszolek ZK. The assessment of sleep disorders by polysomnography. Adv Clin Neurosci 1997; 7:249-68.
  268. Calne DB, Deutch A, Gasser T, Goldstein M, Guttman M, Mizumo Y, Yahr M, Wszolek Z. Genes and Parkinson's disease. Parkinson Network 1997; 82:17-18.
  269. Wszolek ZK, Lynch T, Wilhelmsen KC. Rapidly progressive autosomal dominant Parkinsonism and dementia with Pallido-Ponto-Nigral degeneration (PPND) and disinhibition- dementia- Parkinsonism-amyotrophy complex (DDPAC) are clinically distinct conditions that are both linked to 17Q21-22. Parkinsonism & Related Disorders 1997; 3:67-76.
  270. Kishore A, Wszolek ZK, Snow BJ, de la Fuente-Fernandez R, Arwert F, Wijker M, Schulzer M, Calne DB, Vingerhoets FJ. Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family. Neurology 1996 Dec; 47(6):1588-90.
    View PubMed
  271. Edwards LL, Wszolek ZK, Normand MM. Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation. Acta Neurol Scand 1996 Nov; 94(5):358-64.
    View PubMed
  272. Gasser T, Muller-Myhsok B, Supala A, Zimmer E, Wieditz G, Wszolek ZK, Vieregge P, Bonifati V, Oertel WH. The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 1996 Nov; 61(5):518-20.
    View PubMed
  273. Wszolek ZK, McCashland TM, Witte RJ, Brandenberg GA, Steg RE. Spinal epidural abscess in a liver transplant recipient. Transplant Proc 1996 Oct; 28(5):2978-9.
    View PubMed
  274. Chelimsky G, Wszolek Z, Chelimsky TC. Gastrointestinal dysfunction in autonomic neuropathy. Semin Neurol 1996 Sep; 16(3):259-68.
    View PubMed
  275. Pavletic ZS, Bishop MR, Markopoulou K, Wszolek ZK. Drug-induced parkinsonism after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996 Jun; 17(6):1185-7.
    View PubMed
  276. Wijker M, Wszolek ZK, Wolters EC, Rooimans MA, Pals G, Pfeiffer RF, Lynch T, Rodnitzky RL, Wilhelmsen KC, Arwert F. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum Mol Genet 1996 Jan; 5(1):151-4.
    View PubMed
  277. Steg RE, Wszolek ZK. Electroencephalographic abnormalities in liver transplant recipients: practical considerations and review. J Clin Neurophysiol 1996 Jan; 13(1):60-8.
    View PubMed
  278. Gasser T, Wszolek Z, Supala A, Trofatter J, Ozelius L, Uitti RJ, Pfeiffer RF, Gusella J, Calne D, Breakefield XO. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes. Adv Neurol 1996; 69:87-95.
    View PubMed
  279. Markopoulou K, Chase BA, Wszolek ZK. Molecular genetics and pathogenesis of neurodegenerative diseases. Adv Clin Neurosci 1996; 6:217-33.
  280. Ashraf W, Wszolek ZK, Pfeiffer RF, Quigley EMM, Normand M, Srb F, Maurer K. Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Parkinson's Disease/Alzheimer's Digest 1996; 3:16-17.
  281. Wszolek ZK, Pfeiffer RF, Denson MA, McComb RD. Danish-American family (family E) with "Parkinson's disease": pitfalls of genetic studies. Parkinsonism & Related Disorders 1996; 2:47-49.
  282. Wszolek ZK, Steg RE. Seizures after liver transplantation. Liver Transplantation & Surgery 1995 Sep; 1(5):334-9.
    View PubMed
  283. Ashraf W, Wszolek ZK, Pfeiffer RF, Normand M, Maurer K, Srb F, Edwards LL, Quigley EM. Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 1995 Sep; 10(5):650-7.
    View PubMed
  284. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995 Sep; 38(3):373-8.
    View PubMed
  285. Ellingson RJ, Wszolek ZK, Kendall JD, Donovan JP, Schafer DF. Brainstem auditory evoked potentials in liver transplant candidates. Nebr Med J 1995 Jul; 80(7):167-70.
    View PubMed
  286. Edwards LL, Normand MM, Wszolek ZK. Cervical dystonia: a review the role of botulinum toxin. Nebr Med J 1995 May; 80(5):109-15.
    View PubMed
  287. Normand MM, Wszolek ZK, Klass DW. Temporal intermittent rhythmic delta activity in electroencephalograms. J Clin Neurophysiol 1995 May; 12(3):280-4.
    View PubMed
  288. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995 Mar; 45(3 Pt 1):502-5.
    View PubMed
  289. Wszolek ZK, Groover RV, Klass DW. Seizures presenting as episodic hypersomnolence. Epilepsia 1995 Jan; 36(1):108-10.
    View PubMed
  290. Wilhelmsen KC, Wszolek ZK. Is there a genetic susceptibility to idiopathic Parkinsonism? Parkinsonism & Related Disorders 1995; 1:73-84.
  291. Denson MA, Wszolek ZK. Familial Parkinsonism: our experience and review. Parkinsonism & Related Disorders 1995; 1:35-46.
  292. Edwards LL, Wszolek ZK, Normand MM. Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation. Acta Neurol Scand 1995; 92:423-9.
    View PubMed
  293. Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 1994 Sep; 36(3):387-96.
    View PubMed
  294. Wszolek ZK, Denson MD. Brain imaging sometimes helpful in Parkinson's disease evaluation. Focus on Parkinson's Disease Parkinson Awareness Center UNMC 1994; 6:4-5.
  295. Wszolek ZK, Cordes M, Calne DB, Munter MD, Cordes I, Pfeifer RF. [Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance]. [German]. Nervenarzt 1993 May; 64(5):331-5.
    View PubMed
  296. Yamada T, McGeer EG, Schelper RL, Wszolek ZK, McGeer PL, Pfeiffer RF, Rodnitzky RL. Histological and biochemical pathology in a family with autosomal dominant Parkinsonism and dementia. Neurology, Psychiatry, and Brain Research 1993; 2:26-35.
  297. Cordes M, Wszolek ZK, Pfeiffer RF, Calne DB. Examination of the presynaptic dopaminergic system using positron emission tomography in a family with autosomal dominant Parkinsonism and dementia due to Pallido-Ponto-Nigral degeneration (PPND). Radio diag 1993; 34:141-145.
  298. Wszolek ZK, Denson MD. Familial Parkinsonism studied at UNMC. Focus on Parkinson's Disease Parkinson Awareness Center UNMC 1993; 5:4-5.
  299. Wszolek ZK, et al. Rapidly progressive autosomal dominant Parkinsonism and dementia with Pallido-Ponto-Nigral degeneration. Focus on Parkinson's Disease 1993; 5:65-66.
  300. Wszolek ZK, Pfeiffer RF, Bhatt MH, Schelper RL, Cordes M, Snow BJ, Rodnitzky RL, Wolters EC, Arwert F, Calne DB. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol 1992 Sep; 32(3):312-20.
    View PubMed
  301. Wszolek ZK, Pfeiffer RF. Genetic considerations in movement disorders. Current Opinion in Neurology & Neurosurgery 1992 Jun; 5(3):324-30.
    View PubMed
  302. Herkes GK, Wszolek ZK, Westmoreland BF, Klass DW. Effects of midazolam on electroencephalograms of seriously ill patients. Mayo Clin Proc 1992 Apr; 67(4):334-8.
    View PubMed
  303. Wszolek ZK, Herkes GK, Lagerlund TD, Kokmen E. Comparison of EEG background frequency analysis, psychologic test scores, short test of mental status, and quantitative SPECT in dementia. Journal of Geriatric Psychiatry & Neurology 1992 Jan-Mar; 5(1):22-30.
    View PubMed
  304. Cordes M, Wszolek ZK, Calne DB, Rodnitzky RL, Pfeiffer RF. Magnetic resonance imaging studies in rapidly progressive autosomal dominant Parkinsonism and dementia with Pallido-Ponto-Nigral degeneration. Neurodegeneration 1992; 1:217-24.
  305. Wszolek ZK, Aksamit AJ, Ellingson RJ, Sharbrough FW, Westmoreland BF, Pfeiffer RF, Steg RE, de Groen PC. Epileptiform electroencephalographic abnormalities in liver transplant recipients. Ann Neurol 1991 Jul; 30(1):37-41.
    View PubMed
  306. Steg RE, Lefkowitz DM, Wszolek Z, Jordan AA Jr. Optic nerve enlargement in acute optic neuritis. Nebr Med J 1990 Oct; 75(10):284-7.
    View PubMed
  307. Wszolek ZK, McComb RD, Pfeiffer RF, Steg RE, Wood RP, Shaw BW Jr, Markin RS. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation 1989 Dec; 48(6):1006-12.
    View PubMed
  308. Gasecki AP, Mawk JR, Hahn FJ, Wszolek ZK, McComb RD, Bennett DR. Neurocysticercosis: a case report. Nebr Med J 1989 Sep; 74(9):275-9.
    View PubMed
  309. Steg RE, Lefkowitz DM, Wszolek Z, Sison AS Jr, Hahn F. Clinical diagnostic imaging. Cerebral venous thrombosis. Nebr Med J 1989 Feb; 74(2):37-41.
    View PubMed
  310. Sullivan JM, Wszolek ZK, Lund G, Pfeiffer RF. Magnetic resonance imaging in thoracic outlet syndrome. Nebr Med J 1988 Mar; 73(3):70-2.
    View PubMed
  311. Wszolek Z, Monsour H, Smith P, Pfeiffer R. Cryptococcal meningoencephalitis with parkinsonian features. Mov Disord 1988; 3(3):271-3.
    View PubMed
  312. Wszolek ZK, Schima EJ, Phalen JJ. Arteriovenous malformation of the brain. Nebr Med J 1987 Dec; 72(12):404-5.
    View PubMed
  313. Wszolek Z. [Echoencephalographic studies in stroke]. [Polish]. Pol Tyg Lek 1982 May 17; 37(12):337-8.
    View PubMed
  314. Wszolek Z, Hawranek M. [Traumatic spinal cord syndromes of the cervical spine]. [Polish]. Chir Narzadow Ruchu Ortop Pol 1982; 47(3):153-7.
    View PubMed
  315. Wszolek Z, Hawranek M. [Echoencephalography in the diagnosis of craniocerebral injuries]. [Polish]. Pol Tyg Lek 1980 Feb 11; 35(6):195-7.
    View PubMed
  316. Gladych-Kielc I, Wszolek Z. [Case of narcolepsy with attacks of cataplexy, parahypnotic paralysis and hypnagogic hallucinations]. [Polish]. Wiad Lek 1979 Dec 15; 32(24):1775-6.
    View PubMed
  317. Glowacki B, Wszolek Z. [Case of hemiplegic migraine with atypical angiographic findings]. [Polish]. Neurol Neurochir Pol 1978 Jul-Aug; 12(4):795-6.
    View PubMed
  318. Frank AR, Wszolek ZK, Jack CR Jr, Boeve BF. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology 2007 Feb 20; 68(8):620-1.
    View PubMed
  319. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neuroscience 2007; 27:3650-3662.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.